ACAD vs PTON · P/E 15, rev $576.0M vs P/E 92, rev $2.45B
ACADIA Pharmaceuticals Inc (ACAD) versus Peloton Interactive Inc (PTON) — a side-by-side from cached financials, not a winner call.
ACADIA Pharmaceuticals Inc (ACAD) is a biotechnology company listed on US.
Peloton Interactive Inc (PTON) is a leisure company listed on NASDAQ.
Latest reported ACAD revenue for 2026-06-30 was $576.0M. Net income was $35.1M. ACAD currently screens at market cap $3.51B and trailing P/E 15.3.
Latest reported PTON revenue for 2026-06-30 was $2.45B. Net income was $63.2M. Revenue was down 1.8% from 2025-06-30 to 2026-06-30. PTON currently screens at market cap $2.39B and trailing P/E 92.2.
ACAD currently screens at market cap $3.51B and trailing P/E 15.3. PTON currently screens at market cap $2.39B and trailing P/E 92.2.
Not investment advice. Open the ACAD and PTON stock pages for the full models.
Not investment advice.